Johnson & Johnson Seeks FDA Emergency Use Authorization for COVID-19 Vaccine
Image courtesy Rutgers University Texas Border Business Newswise - Rutgers was the second-largest Phase 3 clinical research trial site for Johnson & Johnson's COVID-19 vaccine, whi…
